National

Smokers under 30 need photo IDs to buy tobacco products

Aug 30, 2024

Washington [US], August 30: The U.S. Food and Drug Administration has mandated more people show photo identification when buying tobacco products, as the health regulator raised the age verification requirement by three years.
As part of a rule finalized by the agency on Thursday, the FDA now requires retailers to verify the age of anyone under 30 when they buy tobacco products, from under 27 previously.
The FDA also said retailers cannot sell tobacco products via vending machine in places where individuals under 21 are present or permitted to enter, from 18 years previously.
The United States has been cracking down on the use of tobacco over the past few years to curb preventable deaths from smoking and other products, as well as stop the use of e-cigarettes by minors.
The World Health Organization had said in May tobacco companies were trying to hook a new generation on nicotine by actively targeting them via social media, sports and music festivals.
The FDA had raised the minimum age for tobacco use to 21 years from 18 in 2019.
According to the American Lung Association, smoking kills more than 480,000 people per year in the United States, making it the leading preventable cause of death in the country.
Source: Fijian Broadcasting Cooperation

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025